The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Yarovoy S.Yu.

Chazov National Medical Research Center of Cardiology

Shchelkova G.V.

Chazov National Medical Research Center of Cardiology

Dinevich E.O.

Chazov National Medical Research Center of Cardiology

Chazova I.E.

Chazov National Medical Research Center of Cardiology

Boitsov S.A.

Chazov National Medical Research Center of Cardiology

Assessment of adherence to treatment in patients with resistant arterial hypertension according to Russian-language literature. A systematic review

Authors:

Yarovoy S.Yu., Shchelkova G.V., Dinevich E.O., Chazova I.E., Boitsov S.A.

More about the authors

Journal: Russian Cardiology Bulletin. 2025;20(4‑2): 101‑111

Read: 710 times


To cite this article:

Yarovoy SYu, Shchelkova GV, Dinevich EO, Chazova IE, Boitsov SA. Assessment of adherence to treatment in patients with resistant arterial hypertension according to Russian-language literature. A systematic review. Russian Cardiology Bulletin. 2025;20(4‑2):101‑111. (In Russ.)
https://doi.org/10.17116/Cardiobulletin202520042101

Recommended articles:
Adhe­rence of patients to acne therapy using systemic isotretinoin. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):483-488

References:

  1. Aksenova AV, Sivakova OA, Blinova NV, et al. Russian Medical Society for Arterial Hypertension expert consensus. Resistant hypertension: detection and management. Terapevticheskii Arkhiv. 2021;93(9):1018-1029 (In Russ.) https://doi.org/10.26442/00403660.2021.09.201007
  2. Kobalava ZhD, Konradi AO, Nedogoda SV, et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020; 25(3):3786. (In Russ.). https://doi.org/10.15829/1560-4071-2020-3-3786
  3. Kobalava ZhD, Konradi AO, Nedogoda SV, et al. 2024 Clinical practice guidelines for Hypertension in adults. Russian Journal of Cardiology. 2024; 29(9):6117. (In Russ.). https://doi.org/10.15829/1560-4071-2024-6117
  4. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal. 2018; 39(33):3021-3104. https://doi.org/10.1093/eurheartj/ehy339
  5. McEvoy JW, McCarthy CP, Bruno RM, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. European Heart Journal. August 2024. https://doi.org/10.1093/eurheartj/ehae178
  6. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018; 71:e13-e115. https://doi.org/10.1161/HYP.0000000000000065
  7. Daugherty SL, Powers JD, Magid DJ, et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation. 2012; 125: 1635-1642. https://doi.org/10.1161/CIRCULATIONAHA.111.068064
  8. Sim JJ, Bhandari SK, Shi J, et al. Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension. Kidney Int. 2015; 88: 622-632.  https://doi.org/10.1038/ki.2015.142
  9. Carey RM, Calhoun DA, Bakris GL, et al. Resistant Hypertension: Detection, evaluation, and management: A scientific statement from the American Heart Association. Hypertension. 2018;72(5). https://doi.org/10.1161/hyp.0000000000000084
  10. Burkhart PV, Sabaté E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh. 2003; 35(3): 207-212. 
  11. Hamrahian SM, Maarouf OH, Fülöp T. A Critical Review of Medication Adherence in Hypertension: Barriers and Facilitators Clinicians Should Consider. Patient Prefer Adherence. 2022; 16: 2749-2757. https://doi.org/10.2147/PPA.S368784
  12. Berra E, Azizi M, Capron A, et al. Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant Hypertension. Hypertension. 2016; 68(2): 297-306.  https://doi.org/10.1161/HYPERTENSIONAHA.116.07464
  13. Poulter NR, Borghi C, Parati G, et al. Medication adherence in hypertension. J Hypertens. 2020; 38(4): 579-587.  https://doi.org/10.1097/HJH.0000000000002294
  14. Chazova IE, Solntseva TD, Sivakova OA, et al. Russian Medical Society for Arterial Hypertension expert consensus. Arterial hypertension and adherence to antihypertensive therapy. Systemic Hypertension. 2024;21(2):7-17 (In Russ.). https://doi.org/10.38109/2075-082X-2024-2-5-15
  15. Rebrova OYu, Fediaeva VK. The Questionnaire to Assess the Risk of Systematic Bias in Non-Randomized Comparative Studies: the Russian-Language Version of the Newcastle-Ottawa Scale. Medical Technologies. Assessment and Choice. 2016; No. 3(25): 14-19 (In Russ.).
  16. Deneka IE, Rodionov AV, Fomin VV. Optimization of blood pressure control in patients with resistant arterial hypertension and visceral obesity. Consilium Medicum. 2022;24(10):671-680. (In Russ.). https://doi.org/10.26442/20751753.2022.10.201856
  17. Mishhenko LA, Matova EA, Serbenjuk EI. Effectiveness of the Triple Single-Pill Combination of Antihypertensive Drugs in Patients with Presumable Resistant Hypertension. Kardiologija V Belarusi. 2020;(4):551-562. (In Russ.). https://doi.org/10.34883/PI.2020.12.4.008
  18. Negmatova G, Sharipova K, Abdulloev F, Sherbadalov A. Gender stereotypes of the personality and family settings in patients with resistant arterial hypertension. Avicenna Bulletin. 2017;19(4):450-456. (In Russ.). https://doi.org/10.25005/2074-0581-2017-19-4-450-456
  19. Zolotenkova OM, Urvantseva IA, Seitov AA. Assessment of adherence to treatment in patients with refractory arterial hypertension. Ural’skij medicinskij zhurnal. 2016;02(135):93-95. (In Russ.).
  20. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24(1):67-74. 
  21. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008; 10(5): 348-354. 
  22. Bourque G, Ilin JV, Ruzicka M, Hundemer GL, Shorr R, Hiremath S. Nonadherence is common in patients with apparent resistant hypertension: a systematic review and meta-analysis. Am J Hypertens. 2023; 36(7):394-403.  https://doi.org/10.1093/ajh/hpad013

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.